Lunai Bioworks Inc. (LNAI) vs Soligenix, Inc. (SNGX)

A side-by-side comparison of Lunai Bioworks Inc. and Soligenix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LNAI

Lunai Bioworks Inc.

$5M

$1.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SNGX

Soligenix, Inc.

$5M

$0.36HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — LNAI vs SNGX

growth of $100 · dividends reinvested · last 1y

LNAI -93.8% (-93.8%/yr)SNGX -89.3% (-89.3%/yr)SNGX compounded faster over this window

LNAI SNGX

LNAI vs SNGX: by the numbers

•SNGX is the larger company ($5M vs $5M market cap).
•Both run net losses; SNGX's is the smaller (0.00% vs -612568.11% net margin).

Metrics side by side

Valuation

Metric	LNAI	SNGX
P/S ratio	244.64	N/A
P/B ratio	N/A	0.80

Profitability

Metric	LNAI	SNGX
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	-612568.11%	0.00%
ROE	N/A	-154.08%
ROIC	N/A	-161.69%

Growth (annualized)

Metric	LNAI	SNGX
Total return CAGR (5Y)	N/A	-72.72%

Go deeper

Full LNAI analysis Full SNGX analysis Interactive comparison tool

Dig into the metrics

Lunai Bioworks ROE Soligenix ROE Lunai Bioworks operating margin Soligenix operating margin Lunai Bioworks revenue growth Soligenix revenue growth Lunai Bioworks free cash flow Soligenix free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.